PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Nephrology and Hypertension, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Division of Kidney and Pancreas Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\', \'Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1111/tid.13759
?:doi
?:hasPublicationType
?:journal
  • Transplant infectious disease : an official journal of the Transplantation Society
is ?:pmid of
?:pmid
?:pmid
  • 34787345
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all